TACSTD2 and neoplasm: Next, we evaluated serial tumor samples (biopsy at diagnosis vs surgical sample of primary tumor vs recurrence) in this population of patients to evaluate the kinetics of Trop‐2 expression levels during clinical evolution (Figure 5).